Sufentanil NanoTab PCA System/15 mcg + morphine IV PCA
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post-Operative Pain
Conditions
Post-Operative Pain
Trial Timeline
Apr 1, 2012 → Dec 1, 2012
NCT ID
NCT01539538About Sufentanil NanoTab PCA System/15 mcg + morphine IV PCA
Sufentanil NanoTab PCA System/15 mcg + morphine IV PCA is a phase 3 stage product being developed by Talphera for Post-Operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01539538. Target conditions include Post-Operative Pain.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01539538 | Phase 3 | Completed |
Competing Products
18 competing products in Post-Operative Pain